Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation.
Journal: Science (New York, N.Y.)
Published: September 03, 2026
Potent Anti-Tumor Activity of the AXL-Targeted Antibody-Drug Conjugate, Mipasetamab Uzoptirine (ADCT-601), in Preclinical Models of Adenoid Cystic Carcinoma.
Journal: Molecular cancer therapeutics
Published: November 04, 2025
Does the level of surgical training influence tonsillectomy outcomes? A prospective randomised study.
Journal: The Journal of laryngology and otology
Published: November 04, 2025
Potent anti-tumor activity of the AXL-targeted antibody-drug conjugate, mipasetamab uzoptirine (ADCT-601), in preclinical models of adenoid cystic carcinoma.
Journal: Molecular cancer therapeutics
Published: November 04, 2025
β-Adrenergic Signaling Promotes Anti-Tumor Immunity in TP53-mutant Oral Squamous Cell Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 04, 2025
Neddylation as a target in PIK3CA-mutated head and neck cancer.
Journal: Biochemical and biophysical research communications
Published: March 19, 2025
Response-Adapted Oncologic Surgery in Cutaneous Squamous Cell Carcinoma: A Paradigm Shift Following Neoadjuvant Immunotherapy.
Journal: Annals of surgical oncology
Published: February 12, 2025
Evaluation and Outcomes of Iatrogenic Oropharyngeal Dysphagia.
Journal: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
Published: November 20, 2024
Multi-Institutional Comparison of Quality of Life Between Open Versus Endoscopic Skull Base Approaches.
Journal: Laryngoscope investigative otolaryngology
Published: October 19, 2024
Spatial biology reveals altered macrophage states in immunosuppressed non-melanoma skin cancer.
Journal: Cell
Published: August 18, 2024
Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC Tumors.
Journal: Molecular cancer therapeutics
Published: July 23, 2024
Last Updated: 09/26/2026